December 2024, Volume 1, Edition 2
Table of Contents

Letter from the Editors

Looking for inspiration for your medtech company as we head into 2025? Here’s what’s on the minds of some thought leaders in our space.

Highlights: Boston Scientific expands its AFib platform, innovative cancer, urology, diabetes and dialysis companies secure later-stage funding, and early-stage neurotech, AI healthtech, and robotics innovators gain runway.

Free article

The medtech M&A landscape in 2024 has soared past the benchmarks of 2023, with innovation, VC and FDA support acting as the engines driving its ascent. As the industry gains altitude, the flight path indicates a bustling and strategically pivotal 2025.

Free article

When it comes to revolutionizing medtech, two names carry heavyweight status: Josh Makower, MD, and Antoine Papiernik. These visionaries, both powerhouses in innovation and venture capital, dish out straight talk following Shockwave Medical’s epic exit on what it really takes to succeed in medtech. For entrepreneurs and investors aiming to make waves, they say the magic formula is all about grit, teamwork, a long-haul mindset, and a relentless commitment to a new form of investor collaboration.

Free article

Driven by an aging population, robotic surgery innovations, sensors and other technologies to detect costly periprosthetic joint infection, and a move to ambulatory surgery centers, the global orthopedic surgery market is on track to reach a value of nearly $70 billion by 2030.

Recent green lights from the FDA and CMS are finally igniting this long-awaited market that 10 years ago faced an uncertain future, unlocking an innovative potential treatment for millions battling uncontrolled hypertension.

Data sourced from LSI’s Global Procedure Volumes Database, which provides trusted coverage of 300+ diagnostic and therapeutic procedures across 37 countries.

Connection, collaboration, community, and transformative opportunities. LSI events bring it all together, with incredible medtech innovators from around the world, in world-class venues like the Ritz-Carlton, Penha Longa Resort in Sintra, Portugal.

Backed by fresh NIH grants, Series A funding, a CPT code, FDA IDE pivotal trial approval, and crowned with a Best Invention of 2024 award, Sonavex exemplifies the playbook for medtech success. CEO David Narrow reveals how embracing challenges, laser-focused execution, and prioritizing market access, reimbursement, and adoption-driving clinical evidence have propelled the company—with the goal of revolutionizing care for hemodialysis patients and their vascular access lifeline.

Celebrating the recent wins of our LSI presenting company and speaker alumni community.

This month we’re showcasing technologies and organizations impacting our industry, and patient lives.

For relatable jokes on our ever-evolving industry and the times in which we’re living, we’ve got the memes you need to brighten your day!

Trusted By The Companies Pioneering What’s Next

Work with us
Accelerate your business
We’re here to help you make smarter decisions and form stronger
partnerships through curated events, independent market intelligence
products and services, and digital-forward media.